Trial Profile
Lymphocyte trafficking and the effect of vedolizumab in pouchitis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Dec 2017
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Pouchitis; Ulcerative colitis
- Focus Therapeutic Use
- 15 Dec 2017 Status changed from not yet recruiting to recruiting.
- 12 Jul 2017 New trial record